Index by author

December 01, 2009; Volume 76,Issue 12

  1. Malki, Monzr Al

    1. An algorithm for managing warfarin resistance
      Olusegun Osinbowale, MD, MBA, RPVI, Monzr Al Malki, MD, Andrew Schade, MD, PhD and John R. Bartholomew, MD
      Cleveland Clinic Journal of Medicine December 2009, 76 (12) 724-730; DOI: https://doi.org/10.3949/ccjm.76a.09062

      Some patients need higher-than-expected doses of warfarin to reach their target INR. The cause can be acquired (poor compliance, drug interactions) or hereditary.

  2. Mandell, Brian F.

    1. Low bone density is not always bisphosphonate deficiency
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine December 2009, 76 (12) 683; DOI: https://doi.org/10.3949/ccjm/76a.12001

      Low bone density is not a one-size-fits-all disorder. We need to carefully consider the diagnostic and therapeutic options before assuming that low bone density is osteoporosis.

  3. Messerli, Franz H.

    1. Is an ACE inhibitor plus an ARB more effective than either drug alone?
      Franz H. Messerli, MD and Melana Yuzefpolskaya, MD
      Cleveland Clinic Journal of Medicine December 2009, 76 (12) 693-696; DOI: https://doi.org/10.3949/ccjm.76a.09052

      No. Dual renin-angiotensin system blockade has never been shown to reduce the rates of morbidity or death from any cause.

  4. Miller, Paul D.

    1. Fragility fractures in chronic kidney disease: An opinion-based approach
      Paul D. Miller, MD
      Cleveland Clinic Journal of Medicine December 2009, 76 (12) 715-723; DOI: https://doi.org/10.3949/ccjm.76a.08108

      When a patient with chronic kidney disease suffers a fragility fracture, a key question is whether the patient has osteoporosis or, instead, renal osteodystrophy. Bone densitometry does not help in this distinction.

Back to top

In this issue